Answers are grounded in this paper and cite their sources.
Background: Breastfeeding is the optimal method of infant feeding. However, the marketing of Commercial Infant Formulas (CIFs) remains one of the major barriers to its practice. This study analyzed health and nutrition claims, and marketing strategies on CIF packaging and labeling in Mexico and assessed compliance with the International Code of Marketing of Breast-milk Substitutes (the International Code) and the Mexican Official Standard. Methods: We conducted a cross-sectional quantitative content analysis of 113 CIF packages collected in supermarkets in Mexico City and Querétaro (August– December 2022), which accounted for 96% of CIF purchase volume in the Kantar Worldpanel. Products were classified as Infant and Follow-on Formulas, Specialized Formulas, or Growing-up Milks/Formulas. Compliance with NOM-131 and the International Code was scored against predefined criteria, and differences across product categories were assessed with Fisher's exact and Kruskal–Wallis tests. Results: Overall, 94.7% of products displayed marketing strategies, 86.7% nutrition claims, and 15.9% health claims. Growing-up Milks/Formulas were the most heavily promoted, with 100% including marketing strategies. No product fully complied with either regulatory framework. High compliance with the Mexican Official Standard and the International Code was observed in 34.5% and 41.6% of CIFs, respectively. Infant and Follow-on Formulas showed the highest compliance, whereas Growing- up Milks/Formulas showed the lowest. Conclusions: CIF packaging and labeling in Mexico is widely used as a promotional tool, particularly for Growing-up Milks/Formulas, highlighting the need to strengthen and update regulations to better protect breastfeeding.
No takes yet. Share an insight, caveat, or question.
Aviles-Contreras et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: